Medifast Inc
MED11.341USD
-0.509-4.30%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
124.65MCap. mercado
495.66P/E TTM
Más Datos de Medifast Inc Compañía
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Información de Medifast Inc
Símbolo de cotizaciónMED
Nombre de la empresaMedifast Inc
Fecha de salida a bolsaDec 30, 1993
Director ejecutivoChard (Daniel R)
Número de empleados504
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 30
Dirección100 International Drive, 18th Floor
CiudadBALTIMORE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal21202
Teléfono14105818042
Sitio Webhttps://medifastinc.com/
Símbolo de cotizaciónMED
Fecha de salida a bolsaDec 30, 1993
Director ejecutivoChard (Daniel R)
Ejecutivos de Medifast Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Desglose de ingresos
FY2025Q2
FY2025Q1
FY2024
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
105.56M
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: mar., 18 de nov
Actualizado: mar., 18 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Otro
69.09%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Otro
69.09%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
34.59%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
17.51%
Research Firm
7.05%
Individual Investor
3.30%
Family Office
0.88%
Pension Fund
0.13%
Bank and Trust
0.12%
Insurance Company
0.03%
Otro
10.85%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
470
8.80M
80.10%
-3.51M
2025Q2
501
8.65M
78.71%
-4.63M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
799.27K
7.27%
-56.13K
-6.56%
Jun 30, 2025
Renaissance Technologies LLC
813.31K
7.4%
-75.62K
-8.51%
Jun 30, 2025
The Vanguard Group, Inc.
795.45K
7.24%
+31.89K
+4.18%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
421.17K
3.83%
+155.60K
+58.59%
Jun 30, 2025
BofA Global Research (US)
396.37K
3.61%
+107.85K
+37.38%
Jun 30, 2025
Two Sigma Investments, LP
419.02K
3.81%
-16.70K
-3.83%
Jun 30, 2025
Acadian Asset Management LLC
411.10K
3.74%
+25.38K
+6.58%
Jun 30, 2025
Parametric Portfolio Associates LLC
323.67K
2.94%
+108.94K
+50.73%
Jun 30, 2025
AQR Capital Management, LLC
220.13K
2%
+20.38K
+10.20%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Acquirers Small and Micro Deep Value ETF
0.79%
Federated Hermes MDT Small Cap Core ETF
0.19%
First Trust Active Factor Small Cap ETF
0.15%
iShares US Small Cap Value Factor ETF
0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.12%
Schwab Fundamental U.S. Small Company ETF
0.06%
iShares US Small-Cap Equity Factor ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.02%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Ver más
Acquirers Small and Micro Deep Value ETF
Proporción0.79%
Federated Hermes MDT Small Cap Core ETF
Proporción0.19%
First Trust Active Factor Small Cap ETF
Proporción0.15%
iShares US Small Cap Value Factor ETF
Proporción0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.12%
Schwab Fundamental U.S. Small Company ETF
Proporción0.06%
iShares US Small-Cap Equity Factor ETF
Proporción0.04%
Franklin US Small Cap Multifactor Index ETF
Proporción0.02%
iShares Micro-Cap ETF
Proporción0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
Dividendos
Un total de
262.40M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Medifast Inc?
Los cinco principales accionistas de Medifast Inc son:
BlackRock Institutional Trust Company, N.A. posee 799.27K acciones, lo que representa el 7.27% del total de acciones.
Renaissance Technologies LLC posee 813.31K acciones, lo que representa el 7.40% del total de acciones.
The Vanguard Group, Inc. posee 795.45K acciones, lo que representa el 7.24% del total de acciones.
Charles Schwab Investment Management, Inc. posee 421.17K acciones, lo que representa el 3.83% del total de acciones.
BofA Global Research (US) posee 396.37K acciones, lo que representa el 3.61% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 799.27K acciones, lo que representa el 7.27% del total de acciones.
Renaissance Technologies LLC posee 813.31K acciones, lo que representa el 7.40% del total de acciones.
The Vanguard Group, Inc. posee 795.45K acciones, lo que representa el 7.24% del total de acciones.
Charles Schwab Investment Management, Inc. posee 421.17K acciones, lo que representa el 3.83% del total de acciones.
BofA Global Research (US) posee 396.37K acciones, lo que representa el 3.61% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Medifast Inc?
Los tres principales tipos de accionista de Medifast Inc son:
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
¿Cuántas instituciones poseen acciones de Medifast Inc (MED)?
A fecha de 2025Q3, 470 instituciones poseen acciones de Medifast Inc, con un valor de mercado combinado de aproximadamente 8.80M, lo que representa el 80.10% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 1.39%.
¿Cuál es la mayor fuente de ganancias de Medifast Inc?
El FY2025Q2, el segmento empresarial -- generó la ganancia más alta para Medifast Inc, ascendiendo a -- y representando el --% de la ganancia total.
